Skip to main content
lexblog.com/lib/M18GWC3Eviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "MHPAEA Red Flags and Best Practices: DOL Guidance Highlights Where Plan Sponsors and Fiduciaries Should Focus Compliance Efforts",
    "url": "https://www.lexblog.com/2026/09/18/mhpaea-red-flags-and-best-practices-dol-guidance-highlights-where-plan-sponsors-and-fiduciaries-should-focus-compliance-efforts/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-M18GWC3E",
        "url": "https://www.lexblog.com/lib/M18GWC3E/"
    },
    "datePublished": "2026-09-18T10:13:36-04:00",
    "dateModified": "2026-09-18T11:16:04-04:00",
    "author": {
        "@type": "Person",
        "name": "Kristin Koenecke, Shira McKinlay, Kim Wilcoxon, Beth A. Mandel"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Thompson Hine LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "ERISA Litigation & Compliance",
    "about": "Corporate Governance and Compliance ยท Health Care and Life Sciences",
    "sourceUrl": "https://www.erisalitigation.com/?p=3441",
    "sourceStability": "may-move"
}